DE2655802A1 - Neue halogenpregnadiene und verfahren zu ihrer herstellung - Google Patents

Neue halogenpregnadiene und verfahren zu ihrer herstellung

Info

Publication number
DE2655802A1
DE2655802A1 DE19762655802 DE2655802A DE2655802A1 DE 2655802 A1 DE2655802 A1 DE 2655802A1 DE 19762655802 DE19762655802 DE 19762655802 DE 2655802 A DE2655802 A DE 2655802A DE 2655802 A1 DE2655802 A1 DE 2655802A1
Authority
DE
Germany
Prior art keywords
acid
group
compounds
formula
esterified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762655802
Other languages
German (de)
English (en)
Inventor
Georg Dr Anner
Charles Dr Meystre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE2655802A1 publication Critical patent/DE2655802A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
DE19762655802 1975-12-12 1976-12-09 Neue halogenpregnadiene und verfahren zu ihrer herstellung Withdrawn DE2655802A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1615075A CH626632A5 (en) 1975-12-12 1975-12-12 Process for the preparation of halopregnadienes

Publications (1)

Publication Number Publication Date
DE2655802A1 true DE2655802A1 (de) 1977-06-16

Family

ID=4414834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762655802 Withdrawn DE2655802A1 (de) 1975-12-12 1976-12-09 Neue halogenpregnadiene und verfahren zu ihrer herstellung

Country Status (19)

Country Link
JP (1) JPS5273852A (fr)
AT (1) AT353432B (fr)
AU (1) AU510864B2 (fr)
BE (1) BE849267A (fr)
CA (1) CA1078824A (fr)
CH (2) CH626632A5 (fr)
DD (1) DD128682A5 (fr)
DE (1) DE2655802A1 (fr)
DK (1) DK142326B (fr)
ES (2) ES454119A1 (fr)
FR (1) FR2358152A1 (fr)
GB (1) GB1563595A (fr)
HU (1) HU176936B (fr)
IE (1) IE44512B1 (fr)
IL (1) IL51085A (fr)
NL (1) NL7613711A (fr)
NZ (1) NZ182865A (fr)
SE (1) SE7613919L (fr)
ZA (1) ZA767381B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid

Also Published As

Publication number Publication date
DK557576A (fr) 1977-06-13
GB1563595A (en) 1980-03-26
SE7613919L (sv) 1977-06-13
ZA767381B (en) 1977-11-30
FR2358152B1 (fr) 1982-10-22
AU510864B2 (en) 1980-07-17
AT353432B (de) 1979-11-12
NL7613711A (nl) 1977-06-14
DK142326B (da) 1980-10-13
JPS5273852A (en) 1977-06-21
IL51085A0 (en) 1977-02-28
DK142326C (fr) 1981-03-09
AU2047176A (en) 1978-06-15
CA1078824A (fr) 1980-06-03
CH626632A5 (en) 1981-11-30
HU176936B (hu) 1981-06-28
IE44512L (en) 1977-06-12
ES465551A1 (es) 1978-09-16
CH626094A5 (en) 1981-10-30
NZ182865A (en) 1979-06-08
FR2358152A1 (fr) 1978-02-10
IL51085A (en) 1980-09-16
BE849267A (fr) 1977-06-10
ES454119A1 (es) 1978-03-01
IE44512B1 (en) 1981-12-30
ATA914176A (de) 1979-04-15
DD128682A5 (de) 1977-12-07

Similar Documents

Publication Publication Date Title
DE2707336C2 (fr)
DE1443958B1 (de) 9 alpha-Chlor- bzw. 9 alpha-Fluor-16 beta-methyl-prednisolon-17-monoester und ein Verfahren zu deren Herstellung
EP0135476A2 (fr) Esters d'acides carboxyliques de stéroides
DE2655570A1 (de) Neue polyhalogensteroide und verfahren zu ihrer herstellung
DE1618065C3 (de) 21-Oxo-23-desoxo-cardenoIide, Verfahren zu deren Herstellung und daraus hergestellte Arzneimittel
DE2715863A1 (de) Verfahren zur herstellung von steroidcarbonsaeuren und ihren estern
DE2743069C2 (de) 21-Chlor-6α-fluor-9α-halogen-11β-hydroxy-16β-methyl-17α-propionyloxy-pregna-1,4-dien-3,20-dion-Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, welche diese Verbindungen enthalten
DE2655802A1 (de) Neue halogenpregnadiene und verfahren zu ihrer herstellung
DE3116891C2 (fr)
DE1618993B1 (de) Verfahren zur Herstellung von 3-(2'-Chloräthylthio)-6-formyl-steroiden
DE2852055A1 (de) 1,4-pregnadien-derivate, verfahren zu deren herstellung und deren verwendung
DE1493178C3 (de) 6 alpha-Fluor-16 alpha-methyl-1,4pregnadien-3,20-dion-derivate und Verfahren zu ihrer Herstellung
AT368521B (de) Verfahren zur herstellung von neuen 2,9 alpha-
DE1807585C3 (de) 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel
DE2707346A1 (de) Neue halogenpregnadiene und verfahren zu ihrer herstellung
EP0077541A1 (fr) Delta-1,3,5-3-chloro-11-bêta, 16-alpha, 17-alpha, 21-tétra-(hydroxy)-pregnane-20-one-16,17-acétonides, procédé pour les préparer et médicaments les contenant
AT368522B (de) Verfahren zur herstellung von neuen 2,9alpha-
DE1930982C3 (de) 6alpha-Fluor-2,9alpha,11 betatrichlor-16alpha-methyl-verbindungen der Pregnanreihe
DE2630270A1 (de) 21-acetale und gemischte 21-acetale von steroid-21-aldehyden, zwischenprodukte und verfahren zur herstellung derselben
AT362889B (de) Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren
DE1568972C (de) Pregna 1,4 dien 9alpha, 1 lbeta dichlor 3,20 dion eckige Klammer auf 17alpha, 16 alpha d eckige Klammer zu 2'methyloxazoline
DE1802962C3 (de) Neue Galpha, 6beta-Dlfluorsteroide, Verfahren zu ihrer Herstellung, sowie diese enthaltende Mittel
AT362888B (de) Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren
CH625254A5 (fr)
DE1593518C3 (de) Verfahren zur Herstellung eines 17 alpha-Esters der Pregnanreihe

Legal Events

Date Code Title Description
8130 Withdrawal